Rocamboli Stephen
- SEC CIK
- 0001221451
No open-market purchases or sales filed in the past year.
Current role at each company
- ESPR Esperion Therapeutics, Inc.Directoras of Jun 2, 2025
- TFFP TFF Pharmaceuticals, Inc.Directoras of Jul 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rocamboli Stephen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TFFP TFF Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 (view filing) | May 16 | 1 day | Rocamboli StephenDirector | PPurchase | +3.00K | $4.54 | +$13.6K | +19.1%18.7K after | |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Rocamboli StephenDirector | PPurchase | +13.0K | $0.80 | +$10.4K | +433.3%16.0K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Rocamboli StephenDirector | PPurchase | +20.0K | $0.25 | +$5.00K | +125.0%36.0K after |
ESPR Esperion Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2023 (view filing) | May 10 | 1 day | Rocamboli StephenDirector | PPurchase | +8.11K | $1.50 | +$12.2K | New position8.11K after |